{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:17:52Z","timestamp":1784744272716,"version":"3.55.0"},"reference-count":79,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02362022"],"award-info":[{"award-number":["RF-2016-02362022"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2018 - ID. 14415"],"award-info":[{"award-number":["IG 2018 - ID. 14415"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2019 - ID. 23264"],"award-info":[{"award-number":["IG 2019 - ID. 23264"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,9,9]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Breast cancer (BC) progression to metastatic disease is the leading cause of death in women worldwide. Metastasis is driven by cancer stem cells (CSCs) and signals from their microenvironment. Interleukin (IL) 30 promotes BC progression, and its expression correlates with disease recurrence and mortality. Whether it acts by regulating BCSCs is unknown and could have significant therapeutic implications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Human (h) and murine (m) BCSCs were tested for their production of and response to IL30 by using flow cytometry, confocal microscopy, proliferation and sphere-formation assays, and PCR array. Immunocompetent mice were used to investigate the role of BCSC-derived IL30 on tumor development and host outcome. TCGA PanCancer and Oncomine databases provided gene expression data from 1084 and 75 hBC samples, respectively, and immunostaining unveiled the BCSC microenvironment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>hBCSCs constitutively expressed IL30 as a membrane-anchored glycoprotein. Blocking IL30 hindered their proliferation and self-renewal efficiency, which were boosted by IL30 overexpression. IL30 regulation of immunity gene expression in human and murine BCSCs shared a significant induction of <jats:italic>IL23<\/jats:italic> and <jats:italic>CXCL10<\/jats:italic>. Both immunoregulatory mediators stimulated BCSC proliferation and self-renewal, while their selective blockade dramatically hindered IL30-dependent BCSC proliferation and mammosphere formation. Orthotopic implantation of IL30-overexpressing mBCSCs, in syngeneic mice, gave rise to poorly differentiated and highly proliferating MYC<jats:sup>+<\/jats:sup>KLF4<jats:sup>+<\/jats:sup>LAG3<jats:sup>+<\/jats:sup> tumors, which expressed CXCL10 and IL23, and were infiltrated by myeloid-derived cells, Foxp3<jats:sup>+<\/jats:sup> T regulatory cells and NKp46<jats:sup>+<\/jats:sup>ROR\u03b3t<jats:sup>+<\/jats:sup> type 3 innate lymphoid cells, resulting in increased metastasis and reduced survival. In tumor tissues from patients with BC, expression of <jats:italic>IL30<\/jats:italic> overlapped with that of <jats:italic>CXCL10<\/jats:italic> and <jats:italic>IL23,<\/jats:italic> and ranked beyond the 95th percentile in a Triple-Negative enriched BC collection from the Oncomine Platform. CIBERSORTx highlighted a defective dendritic cell, CD4<jats:sup>+<\/jats:sup> T and \u03b3\u03b4 T lymphocyte content and a prominent LAG3 expression in IL30<jats:sup>high<\/jats:sup> \n                     <jats:italic>versus<\/jats:italic> IL30<jats:sup>low<\/jats:sup> human BC samples from the TCGA PanCancer collection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Constitutive expression of membrane-bound IL30 regulates BCSC viability by juxtacrine signals and <jats:italic>via<\/jats:italic> second-level mediators, mainly CXCL10 and IL23. Their autocrine loops mediate much of the CSC growth factor activity of IL30, while their paracrine effect contributes to IL30 shaping of immune contexture. IL30-related immune subversion, which also emerged from computational analyses, strongly suggests that targeting IL30 can restrain the BCSC compartment and counteract BC progression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2021-002966","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T20:34:34Z","timestamp":1634589274000},"page":"e002966","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome"],"prefix":"10.1136","volume":"9","author":[{"given":"Carlo","family":"Sorrentino","sequence":"first","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"},{"name":"Anatomic Pathology and Immuno-Oncology Unit, Center for Advanced Studies and Technology (CAST), \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania Livia","family":"Ciummo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"},{"name":"Anatomic Pathology and Immuno-Oncology Unit, Center for Advanced Studies and Technology (CAST), \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"D'Antonio","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"},{"name":"Anatomic Pathology and Immuno-Oncology Unit, Center for Advanced Studies and Technology (CAST), \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7203-6545","authenticated-orcid":false,"given":"Cristiano","family":"Fieni","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"},{"name":"Anatomic Pathology and Immuno-Oncology Unit, Center for Advanced Studies and Technology (CAST), \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lanuti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Turdo","sequence":"additional","affiliation":[{"name":"Department of Health Promotion Sciences, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Todaro","sequence":"additional","affiliation":[{"name":"Department of Health Promotion Sciences, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-1042","authenticated-orcid":false,"given":"Emma","family":"Di Carlo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sciences of Aging, \"G. d'Annunzio\" University\u201d of Chieti-Pescara, Chieti, Italy"},{"name":"Anatomic Pathology and Immuno-Oncology Unit, Center for Advanced Studies and Technology (CAST), \"G. d'Annunzio\" University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"2025100304263638000_9.10.e002966.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937"},{"key":"2025100304263638000_9.10.e002966.2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcancer.2018.07.007","article-title":"Breast cancer stem cells: features, key drivers and treatment options","volume":"53","author":"Dittmer","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"2025100304263638000_9.10.e002966.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.07.004"},{"key":"2025100304263638000_9.10.e002966.4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3117"},{"key":"2025100304263638000_9.10.e002966.5","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0668-z"},{"key":"2025100304263638000_9.10.e002966.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00324-2"},{"key":"2025100304263638000_9.10.e002966.7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.158"},{"key":"2025100304263638000_9.10.e002966.8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1425"},{"key":"2025100304263638000_9.10.e002966.9","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.18632\/oncotarget.2797","article-title":"Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer","volume":"6","author":"Airoldi","year":"2015","journal-title":"Oncotarget"},{"key":"2025100304263638000_9.10.e002966.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2012.04.001"},{"key":"2025100304263638000_9.10.e002966.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.03.136"},{"key":"2025100304263638000_9.10.e002966.12","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030615","article-title":"Decoding the role of interleukin-30 in the crosstalk between cancer and myeloid cells","volume":"9","author":"Di Carlo","year":"2020","journal-title":"Cells"},{"key":"2025100304263638000_9.10.e002966.13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.432955"},{"key":"2025100304263638000_9.10.e002966.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2240"},{"key":"2025100304263638000_9.10.e002966.15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0189"},{"key":"2025100304263638000_9.10.e002966.16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3452"},{"key":"2025100304263638000_9.10.e002966.17","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040375"},{"key":"2025100304263638000_9.10.e002966.18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.278","article-title":"Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFN\u03b3 signaling","volume":"11","author":"Sorrentino","year":"2021","journal-title":"Clin Transl Med"},{"key":"2025100304263638000_9.10.e002966.19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070965","article-title":"Targeting cancer stem cells in triple-negative breast cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers"},{"key":"2025100304263638000_9.10.e002966.20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0248"},{"key":"2025100304263638000_9.10.e002966.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0615-y"},{"key":"2025100304263638000_9.10.e002966.22","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-77-18779"},{"key":"2025100304263638000_9.10.e002966.23","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.017830"},{"key":"2025100304263638000_9.10.e002966.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.06.008"},{"key":"2025100304263638000_9.10.e002966.25","doi-asserted-by":"publisher","DOI":"10.3758\/BRM.41.4.1149"},{"key":"2025100304263638000_9.10.e002966.26","unstructured":"Rosner B . Fundamentals of biostatistics. 7th edn. Boston, MA: Brooks\/Cole, 2011."},{"key":"2025100304263638000_9.10.e002966.27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"},{"key":"2025100304263638000_9.10.e002966.28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025100304263638000_9.10.e002966.29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337"},{"key":"2025100304263638000_9.10.e002966.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1816698116"},{"key":"2025100304263638000_9.10.e002966.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3031"},{"key":"2025100304263638000_9.10.e002966.32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5699"},{"key":"2025100304263638000_9.10.e002966.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.12.018"},{"key":"2025100304263638000_9.10.e002966.34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","article-title":"Breast cancer lung metastasis: molecular biology and therapeutic implications","volume":"19","author":"Jin","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"2025100304263638000_9.10.e002966.35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1532"},{"key":"2025100304263638000_9.10.e002966.36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/path.2728","article-title":"Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay","volume":"221","author":"Waddell","year":"2010","journal-title":"J Pathol"},{"key":"2025100304263638000_9.10.e002966.37","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2025100304263638000_9.10.e002966.38","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4049\/jimmunol.139.7.2317","article-title":"Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts","volume":"139","author":"Kurt-Jones","year":"1987","journal-title":"J Immunol"},{"key":"2025100304263638000_9.10.e002966.39","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V93.10.3531.410k32_3531_3539","article-title":"Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15","volume":"93","author":"Musso","year":"1999","journal-title":"Blood"},{"key":"2025100304263638000_9.10.e002966.40","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(88)90112-5"},{"key":"2025100304263638000_9.10.e002966.41","first-page":"149","article-title":"Identification of soluble and membrane-bound isoforms of the murine FLT3 ligand generated by alternative splicing of mRNAs","volume":"10","author":"Lyman","year":"1995","journal-title":"Oncogene"},{"key":"2025100304263638000_9.10.e002966.42","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90486-2"},{"key":"2025100304263638000_9.10.e002966.43","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90574-A"},{"key":"2025100304263638000_9.10.e002966.44","doi-asserted-by":"publisher","DOI":"10.1038\/385640a0"},{"key":"2025100304263638000_9.10.e002966.45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.5.629"},{"key":"2025100304263638000_9.10.e002966.46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260141"},{"key":"2025100304263638000_9.10.e002966.47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-017-1353-6","article-title":"Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis","volume":"19","author":"Lee","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2025100304263638000_9.10.e002966.48","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.002151"},{"key":"2025100304263638000_9.10.e002966.49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2386"},{"key":"2025100304263638000_9.10.e002966.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.03.021"},{"key":"2025100304263638000_9.10.e002966.51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.689286","article-title":"The C-X-C motif chemokine ligand 1 sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape programs","volume":"9","author":"Ciummo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025100304263638000_9.10.e002966.52","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.591"},{"key":"2025100304263638000_9.10.e002966.53","first-page":"2019","article-title":"The role of granulocyte colony\u2011stimulating factor in breast cancer development: a review","volume":"21","author":"Liu","year":"2020","journal-title":"Mol Med Rep"},{"key":"2025100304263638000_9.10.e002966.54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102048"},{"key":"2025100304263638000_9.10.e002966.55","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00114"},{"key":"2025100304263638000_9.10.e002966.56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2761"},{"key":"2025100304263638000_9.10.e002966.57","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0066-6"},{"key":"2025100304263638000_9.10.e002966.58","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1096"},{"key":"2025100304263638000_9.10.e002966.59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046342"},{"key":"2025100304263638000_9.10.e002966.60","first-page":"287","article-title":"CXCR3, a double-edged sword in tumor progression and angiogenesis","volume":"2013","author":"Billottet","year":"1836","journal-title":"Biochim Biophys Acta"},{"key":"2025100304263638000_9.10.e002966.61","article-title":"The chemokine receptor CXCR3 isoform B drives breast cancer stem cells","volume":"13","author":"Kundu","year":"2019","journal-title":"Breast Cancer"},{"key":"2025100304263638000_9.10.e002966.62","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00271","article-title":"The role of CXCR3 and its chemokine ligands in skin disease and cancer","volume":"5","author":"Kuo","year":"2018","journal-title":"Front Med"},{"key":"2025100304263638000_9.10.e002966.63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0579"},{"key":"2025100304263638000_9.10.e002966.64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71951"},{"key":"2025100304263638000_9.10.e002966.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.04.005"},{"key":"2025100304263638000_9.10.e002966.66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190297"},{"key":"2025100304263638000_9.10.e002966.67","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0282-9"},{"key":"2025100304263638000_9.10.e002966.68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0598"},{"key":"2025100304263638000_9.10.e002966.69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3458"},{"key":"2025100304263638000_9.10.e002966.70","doi-asserted-by":"publisher","DOI":"10.1038\/nature04808"},{"key":"2025100304263638000_9.10.e002966.71","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24083"},{"key":"2025100304263638000_9.10.e002966.72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2019.01.052","article-title":"Determination of the target proteins in chemotherapy resistant breast cancer stem cell-like cells by protein array","volume":"848","author":"Kars","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"2025100304263638000_9.10.e002966.73","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909"},{"key":"2025100304263638000_9.10.e002966.74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax9364"},{"key":"2025100304263638000_9.10.e002966.75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201892"},{"key":"2025100304263638000_9.10.e002966.76","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0513"},{"key":"2025100304263638000_9.10.e002966.77","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s12276-021-00576-0","article-title":"Function of \u03b3\u03b4 T cells in tumor immunology and their application to cancer therapy","volume":"53","author":"Park","year":"2021","journal-title":"Exp Mol Med"},{"key":"2025100304263638000_9.10.e002966.78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0717-275RR","article-title":"\u03b3\u03b4 cells and tumor microenvironment: a helpful or a dangerous liason?","volume":"103","author":"Lo Presti","year":"2018","journal-title":"J Leukoc Biol"},{"key":"2025100304263638000_9.10.e002966.79","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/bloodadvances.2019001390","article-title":"LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma","volume":"4","author":"Keane","year":"2020","journal-title":"Blood Adv"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2021-002966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:26:45Z","timestamp":1759490805000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2021-002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,18]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/jitc-2021-002966"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2021-002966","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}